U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07204314) titled 'A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder' on Sept. 30.
Brief Summary: The main aim of the study is to check how well vortioxetine 10 mg/day or 20 mg/day works and to check for side effects compared to a placebo on depression symptoms in Japanese teenagers aged 12 to 17 years with a diagnosis of Major Depressive Disorder (MDD).
The overall time each participant will be in the study is about 20 weeks. This includes up to 15 days (about 2 weeks) to check who can take part, a 14-week period where everyone receives vortioxetine or a placebo, and after that, a 4-week period to check for any sid...